Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005006543 | SCV005630897 | uncertain significance | Bardet-Biedl syndrome 4 | 2024-06-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004750125 | SCV005367101 | uncertain significance | BBS4-related disorder | 2024-09-27 | no assertion criteria provided | clinical testing | The BBS4 c.983G>A variant is predicted to result in the amino acid substitution p.Ser328Asn. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |